Praluent and Anal neoplasm - from FDA reports


Summary

There is no Anal neoplasm reported by people who take Praluent yet. This review analyzes which people have Anal neoplasm with Praluent. It is created by eHealthMe based on reports from FDA, and is updated regularly.

What to expect?

If you take Praluent and have Anal neoplasm, find out what symptoms you could have in 1 year or longer.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Dec, 12, 2017

No report is found.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Do you have Anal neoplasm when taking Praluent?

Expand the study to include all drugs with the same ingredients

Anal neoplasm and drugs with ingredients of alirocumab.

Expand the study to include reports from both FDA and eHealthMe

Anal neoplasm and Praluent from FDA and eHealthMe reports

Praluent

Praluent has active ingredients of alirocumab. (latest outcomes from Praluent 4,105 users)

Anal Neoplasm

Anal neoplasm (anal cancer) has been reported by people with crohn's disease, rheumatoid arthritis, high blood pressure, relapsing-remitting multiple sclerosis, birth control (latest reports from 44 Anal neoplasm patients).

Browse all side effects of Praluent

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Anal neoplasm

Anal neoplasm

Could your condition cause Anal neoplasm

Anal neoplasm

Related studies

What would happen?

Forecast new side effects and undetected conditions when you take Praluent and have Anal neoplasm.

Questions to the study

More questions >

User reviews to the study

More reviews >